1. Generic Substitution of Orphan Drugs for the Treatment of Rare Diseases: Exploring the Potential Challenges

   • Antonello Di Paolo
   • Elena Arrigoni

   Current Opinion 20 February 2018 Pages: 399 - 410

   

2. Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs

   • Jonathan Jia Yuan Ong
   • Diana Yi-Ting Wei
   • Peter J. Goadsby

   Review Article 02 February 2018 Pages: 411 - 437

   

3. Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?

   • Anouk E. Muller
   • Benedikt Huttner
   • Angela Huttner

   Review Article 23 February 2018 Pages: 439 - 451

   

4. Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

   • Kamal Awad
   • Dimitri P. Mikhailidis
   • on behalf of Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group

   Systematic Review 02 February 2018 Pages: 453 - 462

   

5. Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes

   • Hillel P. Cohen
   • Andrew Blauvelt
   • Gillian Woollett

   Systematic Review Open access 03 March 2018 Pages: 463 - 478

   

6. Ferric Carboxymaltose: A Review in Iron Deficiency

   • Lesley J. Scott

   Adis Drug Evaluation 12 March 2018 Pages: 479 - 493

7. Brodalumab: A Review in Moderate to Severe Plaque Psoriasis

   • Hannah A. Blair

   Adis Drug Evaluation 08 March 2018 Pages: 495 - 504

8. Benralizumab: First Global Approval

   • A. Markham

   AdisInsight Report 20 February 2018 Pages: 505 - 511

   

9. Ertugliflozin: First Global Approval

   • Anthony Markham

   AdisInsight Report 23 February 2018 Pages: 513 - 519

   

10. Correction to: Lonoctocog Alfa: A Review in Haemophilia A

    • Zaina T. Al-Salama
    • Lesley J. Scott

    Correction 03 March 2018 Pages: 521 - 521

11. Correction to: Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence

    • Joshua J. Gagne
    • Jennifer M. Polinski
    • Aaron S. Kesselheim

    Correction 08 March 2018 Pages: 523 - 524